Loader

Pathways

PathWhiz ID Pathway Meta Data

PW146150

Pw146150 View Pathway
drug action

Protirelin Drug Metabolism Action Pathway

Homo sapiens

PW064773

Pw064773 View Pathway
signaling

Protocadherin Fat 1

Homo sapiens

PW145815

Pw145815 View Pathway
drug action

Protokylol Drug Metabolism Action Pathway

Homo sapiens

PW144470

Pw144470 View Pathway
drug action

Protriptyline Drug Metabolism Action Pathway

Homo sapiens

PW176124

Pw176124 View Pathway
metabolic

Protriptyline Predicted Metabolism Pathway new

Homo sapiens
Metabolites of Protriptyline are predicted with biotransformer.

PW132492

Pw132492 View Pathway
metabolic

Proxibarbal Drug Metabolism

Homo sapiens
Proxibarbal is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Proxibarbal passes through the liver and is then excreted from the body mainly through the kidney.

PW146622

Pw146622 View Pathway
drug action

Proxibarbal Drug Metabolism Action Pathway

Homo sapiens

PW450366

Pw450366 View Pathway
metabolic

PRPP Biosynthesis

Bacteroides stercoris ATCC 43183
The biosynthesis of phosphoribosyl pyrophosphate begins as a product of the pentose phosphate and D-ribose 5-phosphate interaction. When catalyzed with a phosphopentomutase, the product is a ribose 1-phosphate. Ribose 1-phosphate can interact spontaneously with ATP resulting in a release of hydrogen ion, ADP and a ribose 1,5-biphosphate. Ribose 1,5-biphosphate is then phosphorylated through a ribose 1,5-bisphosphokinase resulting in the release of ADP and phosphoribosyl pyrophosphate. Phosphoribosyl pyrophosphate will then participate in the purine nucleotides de novo biosynthesis pathway. Alternatively pentose phosphate and D-ribose 5-phosphate's interaction can be phosphorylated through an ATP driven ribose-phosphate diphosphokinase resulting in a release of a hydrogen ion, an AMP and a phosphoribosyl pyrophosphate which will again participate in the purine nucleotides de novo biosynthesis pathway.

PW450765

Pw450765 View Pathway
metabolic

PRPP Biosynthesis

Methylococcus capsulatus
The biosynthesis of phosphoribosyl pyrophosphate begins as a product of the pentose phosphate and D-ribose 5-phosphate interaction. When catalyzed with a phosphopentomutase, the product is a ribose 1-phosphate. Ribose 1-phosphate can interact spontaneously with ATP resulting in a release of hydrogen ion, ADP and a ribose 1,5-biphosphate. Ribose 1,5-biphosphate is then phosphorylated through a ribose 1,5-bisphosphokinase resulting in the release of ADP and phosphoribosyl pyrophosphate. Phosphoribosyl pyrophosphate will then participate in the purine nucleotides de novo biosynthesis pathway. Alternatively pentose phosphate and D-ribose 5-phosphate's interaction can be phosphorylated through an ATP driven ribose-phosphate diphosphokinase resulting in a release of a hydrogen ion, an AMP and a phosphoribosyl pyrophosphate which will again participate in the purine nucleotides de novo biosynthesis pathway.

PW455392

Pw455392 View Pathway
metabolic

PRPP Biosynthesis

Providencia alcalifaciens DSM 30120
The biosynthesis of phosphoribosyl pyrophosphate begins as a product of the pentose phosphate and D-ribose 5-phosphate interaction. When catalyzed with a phosphopentomutase, the product is a ribose 1-phosphate. Ribose 1-phosphate can interact spontaneously with ATP resulting in a release of hydrogen ion, ADP and a ribose 1,5-biphosphate. Ribose 1,5-biphosphate is then phosphorylated through a ribose 1,5-bisphosphokinase resulting in the release of ADP and phosphoribosyl pyrophosphate. Phosphoribosyl pyrophosphate will then participate in the purine nucleotides de novo biosynthesis pathway. Alternatively pentose phosphate and D-ribose 5-phosphate's interaction can be phosphorylated through an ATP driven ribose-phosphate diphosphokinase resulting in a release of a hydrogen ion, an AMP and a phosphoribosyl pyrophosphate which will again participate in the purine nucleotides de novo biosynthesis pathway.